Animal health impacted by climate change

Written by IFAH-Europe on 2 December 2015 in Press Release
Press Release

Brussels, 2 December 2015 - With global heads of state meeting civil society representatives and UN agencies in Paris to discuss climate change at the COP21 event (30 November - 11 December), the animal health industry in Europe highlights the impact of climate change on animal disease and the need for innovation in veterinary medicines.

Brussels, 2 December 2015 - With global heads of state meeting civil society representatives and UN agencies in Paris to discuss climate change at the COP21 event (30 November - 11 December), the animal health industry in Europe highlights the impact of climate change on animal disease and the need for innovation in veterinary medicines.

"With temperatures becoming more clement across the continent we are seeing incidences of animal diseases in Europe that were not previously reported such as the introduction of Schmallenberg virus in 2011 from Africa or the threat of Rift Valley Fever moving into Europe. Climate change and activity such as the creation of wetlands to offset impacts may increase the presence of vectors such as ticks, mosquitoes and fleas, increasing the threat of transmissible diseases", said Roxane Feller, IFAH-Europe Secretary General.

Many vector-borne diseases1 currently lack effective medicines for treatment and prevention. Vaccination has the potential to be one of the most effective methods in dealing with these diseases, but investment in this area is often constrained by the huge costs and resources needed for research which is currently not offered adequate data protection.

Animal health companies are dedicated to bringing new veterinary medicines to market, a highly costly process (up to €129m) that can take between 5 to 11 years to complete. IFAH-Europe calls for incentives for companies to expand the range of medicines available and to develop innovative solutions for animal disease prevention and treatment.

Climate change affects us all, and it may lead to Europe seeing more diseases - new to both us and our animals - than ever before. We need innovation and vaccine banks to be ready to deal with these.

 

About the author

IFAH-Europe is the representative body of manufacturers of veterinary medicines, vaccines and other animal health products in Europe. It promotes a single market in veterinary medicines across the EU ensuring the availability of medicines to protect the health and welfare of animals. For further information on IFAH-Europe, please visit www.ifaheurope.org.

1 - Vector-borne diseases are infections transmitted by the bite of infected insect species, such as mosquitoes, ticks, triatomine bugs, sandflies, and blackflies. They are cold-blooded and thus especially sensitive to climatic factors.

 

For further press information please contact

Kim Hardie, Communications Director
Tel.: +32 2 543 75 75
E-mail: k.hardie@ifahsec.org

 

 

Share this page

Tags

Categories

Partner content

This content is published by the Parliament Magazine on behalf of our partners.

Related Partner Content

New rules breaking down barriers to innovation in animal health
21 March 2018

As trilogue negotiations progress, there are numerous ways in which the new rules on animal medicines can shape up to deliver on objectives to foster innovation for improving the health and...

Inhumane inaction on pharmaceutical pollution
7 September 2018

The release of pharmaceuticals into the environment has significant detrimental effects on human health, write Sirpa Kärenlampi and Angelica Lindsey-Clark.

PM+: EU disregarding its own rules on animal exports
31 March 2015

Live animals export trade is marring the EU's reputation as a leader in animal protection, says Olga Kikou.